Kim JJ - Search Results

1

Optimal interval for routine cytologic screening in the United States.

Kim JJ, Sharma M, Ortendahl J. Kim JJ, et al. JAMA Intern Med. 2013 Feb 11;173(3):241-2. doi: 10.1001/2013.jamainternmed.1034. JAMA Intern Med. 2013. PMID: 23530274 Free PMC article. No abstract available.

2

Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States.

Kim JJ, Ortendahl J, Goldie SJ. Kim JJ, et al. Ann Intern Med. 2009 Oct 20;151(8):538-45. doi: 10.7326/0003-4819-151-8-200910200-00007. Ann Intern Med. 2009. PMID: 19841455 Free PMC article.

3

Cost-effectiveness of human papillomavirus vaccination and screening in Spain.

Diaz M, de Sanjose S, Ortendahl J, O'Shea M, Goldie SJ, Bosch FX, Kim JJ. Diaz M, et al. Among authors: kim jj. Eur J Cancer. 2010 Nov;46(16):2973-85. doi: 10.1016/j.ejca.2010.06.016. Epub 2010 Jul 16. Eur J Cancer. 2010. PMID: 20638840

4

Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa.

Campos NG, Kim JJ, Castle PE, Ortendahl JD, O'Shea M, Diaz M, Goldie SJ. Campos NG, et al. Among authors: kim jj. Int J Cancer. 2012 Jun 1;130(11):2672-84. doi: 10.1002/ijc.26269. Epub 2011 Aug 24. Int J Cancer. 2012. PMID: 21717458 Free PMC article.

5

Using HPV prevalence to predict cervical cancer incidence.

Sharma M, Bruni L, Diaz M, Castellsagué X, de Sanjosé S, Bosch FX, Kim JJ. Sharma M, et al. Among authors: kim jj. Int J Cancer. 2013 Apr 15;132(8):1895-900. doi: 10.1002/ijc.27835. Epub 2012 Oct 11. Int J Cancer. 2013. PMID: 22965284

6

Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).

Kim JJ, Sharma M, O'Shea M, Sweet S, Diaz M, Sancho-Garnier H, Seoud M. Kim JJ, et al. Vaccine. 2013 Dec 30;31 Suppl 6:G65-77. doi: 10.1016/j.vaccine.2012.06.096. Vaccine. 2013. PMID: 24331822

7

Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.

Berkhof J, Bogaards JA, Demirel E, Diaz M, Sharma M, Kim JJ. Berkhof J, et al. Among authors: kim jj. Vaccine. 2013 Dec 31;31 Suppl 7:H71-9. doi: 10.1016/j.vaccine.2013.04.086. Vaccine. 2013. PMID: 24332299

8

An updated natural history model of cervical cancer: derivation of model parameters.

Campos NG, Burger EA, Sy S, Sharma M, Schiffman M, Rodriguez AC, Hildesheim A, Herrero R, Kim JJ. Campos NG, et al. Among authors: kim jj. Am J Epidemiol. 2014 Sep 1;180(5):545-55. doi: 10.1093/aje/kwu159. Epub 2014 Jul 31. Am J Epidemiol. 2014. PMID: 25081182 Free PMC article. Clinical Trial.

9

An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China.

Levin CE, Sharma M, Olson Z, Verguet S, Shi JF, Wang SM, Qiao YL, Jamison DT, Kim JJ. Levin CE, et al. Among authors: kim jj. Vaccine. 2015 Jun 4;33(24):2830-41. doi: 10.1016/j.vaccine.2015.02.052. Epub 2015 Mar 12. Vaccine. 2015. PMID: 25770785 Free article.

10

Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries.

Campos NG, Sharma M, Clark A, Kim JJ, Resch SC. Campos NG, et al. Among authors: kim jj. PLoS One. 2016 Oct 6;11(10):e0164000. doi: 10.1371/journal.pone.0164000. eCollection 2016. PLoS One. 2016. PMID: 27711124 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,466 results

Search Page

Filters